Patents Assigned to Bethesda Eye Institute
  • Patent number: 5292509
    Abstract: A method for selectively and completely disinserting the ocular vitreous body, epiretinal membranes and/or fibrocellular membranes from the neural retina, ciliary epithelium and posterior lens surface of the mammalian eye as an adjunct to vitrectomy comprises administering to the eye an effective amount of a protease-free glycosaminoglycanase enzyme, such as chondroitinase ABC, adapted to disrupt and/or degrade chondroitin sulfate glycosaminoglycan/proteoglycan localized specifically to sites of vitreoretinal adhesion and thereby permit complete disinsertion of the vitreous body and/or epiretinal membranes.
    Type: Grant
    Filed: June 5, 1992
    Date of Patent: March 8, 1994
    Assignee: Bethesda Eye Institute
    Inventor: Gregory S. Hageman